BFG
LXRX icon

Berger Financial Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Berger Financial Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24K Hold
10,000
– – ﹤0.01% 484
2026
Q1 		$15.6K Hold
10,000
– – ﹤0.01% 473
2025
Q4 		$11.5K Sell
10,000
-929
-9% -$1.28K ﹤0.01% 473
2025
Q3 		$14.8K Hold
10,929
– – ﹤0.01% 444
2025
Q2 		$10.3K Hold
10,929
– – ﹤0.01% 419
2025
Q1 		$5.04K Hold
10,929
– – ﹤0.01% 414
2024
Q4 		$8.07K Hold
10,929
– – ﹤0.01% 411
2024
Q3 		$17.2K Hold
10,929
– – ﹤0.01% 391
2024
Q2 		$18.4K Hold
10,929
– – ﹤0.01% 363
2024
Q1 		$26.2K Hold
10,929
– – ﹤0.01% 360
2023
Q4 		$16.7K Hold
10,929
– – ﹤0.01% 305
2023
Q3 		$11.9K Hold
10,929
– – ﹤0.01% 277
2023
Q2 		$25K Hold
10,929
– – ﹤0.01% 288
2023
Q1 		$26.6K Hold
10,929
– – ﹤0.01% 268
2022
Q4 		$20.9K Hold
10,929
– – ﹤0.01% 260
2022
Q3 		$26K Hold
10,929
– – ﹤0.01% 233
2022
Q2 		$20K Hold
10,929
– – ﹤0.01% 242
2022
Q1 		$23K Buy
+10,929
New +$30.3K ﹤0.01% 269

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Berger Financial Group's LXRX Position: Q2 2026 in Review

Berger Financial Group held its Lexicon Pharmaceuticals (LXRX) position steady in Q2 2026 at 10,000 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #484.

Berger Financial Group first reported a position in LXRX in Q1 2022 and has held it in 18 quarters since. The position peaked at $26.6K in Q1 2023. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Berger Financial Group held 10,000 shares of Lexicon Pharmaceuticals worth $24K as of Q2 2026.
  • Berger Financial Group left its Lexicon Pharmaceuticals share count unchanged in Q2 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Berger Financial Group's portfolio in Q2 2026, its #484 holding.
  • Berger Financial Group first reported a position in Lexicon Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • Berger Financial Group's Lexicon Pharmaceuticals position peaked at $26.6K in Q1 2023.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Berger Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.